Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics

. 2014 Jan ; 37 (1) : 117-24. [epub] 20130529

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid23716275

Alu-mediated tandem duplication of exons 4 and 5 (g.15815_22218dup6404) is a novel mutation that has been detected in the LAMP2 gene (Xq24). This exon copy number variation was found in two brothers with the typical phenotype of Danon disease, including characteristic myocardial changes on magnetic resonance imaging. The 6.4 kb duplication was identified in both boys by a combination of exon dosage qPCR analyses and duplication breakpoint/junction mapping. The rearrangement results in a plethora of abnormal LAMP2 splicing variants and also in use of likely cryptic splice sites in the 3' terminus of LAMP2 gene. Although we found minute amounts of normal LAMP2B and LAMP2A mRNAs, no protein was detectable in peripheral blood leukocytes by flow cytometry in both brothers. Uniquely, the fraction of LAMP2-deficient granulocytes (0.06%) assessed by flow cytometry in the patients' asymptomatic mother substantially differed from the random distribution of X-chromosome inactivation in her leukocytes. This discrepancy was later explained by molecular genetic methods as a consequence of mosaic distribution of the mutation in her somatic tissues. Altogether, we report a novel and mosaically distributed exon copy number rearrangement in the LAMP2 gene and comment on obstacles this genetic setup presents to the overall cellular and molecular diagnostic algorithm of Danon disease. Our observations of the mosaicism in the asymptomatic mother suggest that similarly affected females could be a potentially under-diagnosed Danon disease carrier group and that LAMP2 flow cytometry, because of its supreme sensitivity, can be an efficient method for pedigree screening.

Zobrazit více v PubMed

Neurology. 1981 Jan;31(1):51-7 PubMed

EMBO J. 2007 Jan 24;26(2):313-24 PubMed

Autophagy. 2013 Mar;9(3):403-9 PubMed

Am J Pathol. 2006 Apr;168(4):1309-20 PubMed

J Cell Biol. 1985 Jul;101(1):85-95 PubMed

Nature. 2000 Aug 24;406(6798):906-10 PubMed

Neurology. 2002 Jun 25;58(12):1773-8 PubMed

Methods. 2001 Dec;25(4):402-8 PubMed

Nature. 2000 Aug 24;406(6798):902-6 PubMed

Gene. 2012 Oct 10;507(2):174-6 PubMed

Cardiology. 2012;121(1):27-30 PubMed

Ann Neurol. 2002 Jul;52(1):122-5 PubMed

Gene. 2012 May 1;498(2):183-95 PubMed

Mol Aspects Med. 2006 Oct-Dec;27(5-6):495-502 PubMed

Biochem Biophys Res Commun. 1995 Oct 13;215(2):757-67 PubMed

Hum Genet. 2001 Jul;109(1):121-4 PubMed

Genet Med. 2011 Jun;13(6):563-8 PubMed

Blood. 2005 Jan 1;105(1):61-6 PubMed

Circ Cardiovasc Genet. 2010 Apr;3(2):129-37 PubMed

J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S115-22 PubMed

J Cell Sci. 2000 Dec;113 Pt 24:4441-50 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...